{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:40:19Z","timestamp":1791344419248,"version":"4.3.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":1217,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1469-0691.2010.03454.x","type":"journal-article","created":{"date-parts":[[2010,12,31]],"date-time":"2010-12-31T06:43:22Z","timestamp":1293777802000},"page":"1264-1267","source":"Crossref","is-referenced-by-count":2,"title":["Differences in daptomycin and vancomycin ex vivo behaviour can lead to false interpretation of negative blood cultures"],"prefix":"10.1016","volume":"17","author":[{"given":"P.","family":"Grohs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Fantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lefort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Gutmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Mainardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2010.03454.x_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/CIRCULATIONAHA.105.165564","volume":"111","author":"Baddour","year":"2005","journal-title":"Circulation"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jac\/dkl017","article-title":"Guidelines for the prophylaxis and treatment of methicillin\u2010resistantStaphylococcus aureus (MRSA) infections in the UK","volume":"57","author":"Gemmell","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin\u2010resistantStaphylococcus aureus clinical strain with reduced vancomycin susceptibility","volume":"40","author":"Hiramatsu","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1128\/AAC.48.1.275-280.2004","article-title":"Vancomycin\u2010resistantStaphylococcus aureus isolate from a patient in Pennsylvania","volume":"48","author":"Tenover","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib5","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1128\/AAC.35.9.1710","article-title":"Pharmacodynamics of daptomycin and vancomycin onEnterococcus faecalis andStaphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs","volume":"35","author":"Hanberger","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib6","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/AAC.32.9.1320","article-title":"Vancomycin concentrations in infected and noninfected human bone","volume":"32","author":"Graziani","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib7","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin\u2010resistantStaphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jac\/dkh546","article-title":"Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram\u2010positive infections","volume":"55","author":"Steenbergen","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/107662903322762833","article-title":"In vitro activities of Daptomycin, Linezolid, and Quinupristin\u2010Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin\u2010intermediateStaphylococcus aureus and vancomycin\u2010resistantEnterococcus faecium","volume":"9","author":"Jevitt","year":"2003","journal-title":"Microb Drug Resist"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib10","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1086\/420818","article-title":"The safety and efficacy of daptomycin for the treatment of complicated skin and skin\u2010structure infections","volume":"38","author":"Arbeit","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib11","first-page":"675","article-title":"Bacteremia and endocarditis due to methicillin\u2010resistantStaphylococcus aureus: the potential role of daptomycin","volume":"3","author":"Bamberger","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused byStaphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.md.0000091185.93122.40","article-title":"A prospective multicenter study ofStaphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance","volume":"82","author":"Chang","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib14","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/JCM.36.12.3731-3733.1998","article-title":"Effectiveness of resins in neutralizing antibiotic activities in Bactec plus Aerobic\/F culture medium","volume":"36","author":"Spaargaren","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib15","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1128\/JCM.33.9.2265-2270.1995","article-title":"Controlled evaluation of Bact\/Alert standard anaerobic and FAN anaerobic blood culture bottles for the detection of bacteremia and fungemia","volume":"33","author":"Wilson","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1469-0691.2000.00142.x","article-title":"Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution","volume":"6","author":"European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)","year":"2000","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0732-8893(00)00164-4","article-title":"Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests","volume":"38","author":"Fuchs","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0022-3476(96)70254-8","article-title":"Volume of blood required to detect common neonatal pathogens","volume":"129","author":"Schelonka","year":"1996","journal-title":"J Pediatr"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1967.03130160073013","article-title":"Studies on the bacteremia of bacterial endocarditis","volume":"202","author":"Werner","year":"1967","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2010.03454.x_bib20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1469-0691.2005.01306.x","article-title":"Monitoring of vancomycin serum levels for the treatment of staphylococcal infections","volume":"12","author":"Kitzis","year":"2006","journal-title":"Clin Microbiol Infect"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14629657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14629657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T04:34:23Z","timestamp":1592195663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14629657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1198743X14629657"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2010.03454.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}